Search clinical trials for: Cyclophosphamide (CY)

Total 3669 results

Shanghai Jiao Tong University School of Medicine

Unknown

Consolidation Chemotherapy After Autologous Stem Cell Transplantation for Lymphoid Malignancies

Effects of Chemotherapy

China
Boston Children's Hospital

Completed

Cylexin for Reduction of Reperfusion Injury in Infant Heart Surgery

Congenital Heart Defects

United States
Hacettepe University

Completed

Reliability and Validity of Turkish Version of PEM-CY

Child

Turkey
Huazhong University of Science and Technology

Completed

Low Dose Cyclophosphamide Treats Genital Warts

Genital Wart

China
Masonic Cancer Center, University of Minnesota

Recruiting

T Cell Receptor α/β TCD HCT in Patients With Fanconi Anemia

Myelodysplastic Syndromes | Fanconi Anemia | Severe Aplastic Anemia

United States
Glycostem Therapeutics BV

Recruiting

Registry of Patients Having Received oNKord®

AML

Switzerland, Germany
Cytavis Biopharma GmbH

Completed

CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy

Melanoma

Germany
Shanghai Jiao Tong University School of Medicine

Unknown

Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL

Lymphoblastic Leukemia, Acute, Adult

China
Cytavis Biopharma GmbH
Charite University, Berlin, Germany; ClinAssess GmbH; Medical University Innsbruck

Terminated

CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer (CY503C2)

Metastatic Colorectal Cancer

Austria, Germany
Glycostem Therapeutics BV

Recruiting

A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia

Acute Myeloid Leukemia

Belgium, Netherlands, Switzerland, France, Germany
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.

Completed

Scleroderma: Cyclophosphamide or Transplantation (SCOT)

Sclerosis | Scleroderma, Systemic | Autoimmune Disease

United States, Canada
Nanfang Hospital of Southern Medical University
Xiangya Hospital of Central South University; Guangzhou First People's Hospital and other collaborators

Completed

BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT

Acute Lymphocytic Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Busulfan | Total Body Irradiation

China
Shanghai GeneChem Co., Ltd.
RenJi Hospital

Unknown

A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus (SLE)

China
Masonic Cancer Center, University of Minnesota

Not yet recruiting

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Gynecologic Cancer | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... and other collaborators

Recruiting

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning | TP53 | Myeloid Tumors

China
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Unknown

Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | Conditions | Mixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia

China
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... and other collaborators

Recruiting

Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning | Myeloid Tumors

China
Capital Research Institute of Pediatrics

Unknown

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

Hematopoietic System--Cancer

China
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia

Neutropenia | Pancytopenia | Aplastic Anemia | Severe Aplastic Anemia

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Astex Therapeutics, Ltd; Susan Cohan Colon Cancer Foundation

Completed

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

High-Dose Cyclophosphamide for Steroid Refractory GVHD

Graft Versus Host Disease

United States
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Unknown

BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

Conditioning | Diffuse Large B-cell Lymphoma | Autologous Hematopoietic Stem Cell Transplantation

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
Merck Sharp & Dohme LLC

Completed

Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer

Metastatic Colorectal Cancer

United States
Peking University People's Hospital

Recruiting

Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia

Refractory Leukemia | Stem Cell Transplant Complications | Relapse Leukemia

China
Peking University People's Hospital

Recruiting

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Leukemia, Myeloid, Acute | Stem Cell Transplant Complications | Leukemia Relapse

China
University of Oxford

Completed

Vaccination in Prostate Cancer (VANCE)

Prostate Cancer

United Kingdom
University of Arizona

Active, not recruiting

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

Lymphoma, Follicular | Myelodysplastic Syndromes | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Marginal Zone Lymphoma | Acute Myelogenous Leukemia | Mantle-Cell Lymphoma | Chronic Myelogenous Leukemia | Lymphoma, Hodgkin | Gray Zone Lymphoma | Lymphoma,Non-Hodgkin | Large Cell Lymphoma | High Risk Undifferentiated...

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Terminated

Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies

Myelodysplastic Syndromes | Leukemia

United States
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Completed

IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT

Acute Myeloid Leukemia | Conditioning | Autologous Hematopoietic Stem Cell Transplantation

China
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Unknown

BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT

Primary Central Nervous System Lymphoma | Conditioning | Autologous Hematopoietic Stem Cell Transplantation

China
Shanghai Jiao Tong University School of Medicine

Completed

Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies

Lymphoid Malignancies

China
Peking University People's Hospital

Recruiting

The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA

Severe Aplastic Anemia

China
Nanfang Hospital of Southern Medical University
Guangzhou First People's Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen... and other collaborators

Unknown

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Multiple Myeloma | Conditioning | Autologous Hematopoietic Stem Cell Transplantation

China
Nanfang Hospital, Southern Medical University

Recruiting

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

Leukemia | Stem Cell Transplant | Cord Blood

China
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Recruiting

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

Myelodysplastic Syndrome | Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning

China
Nanfang Hospital of Southern Medical University
Liuzhou Workers Hospital; Peking University People's Hospital; Sun Yat-Sen Memorial... and other collaborators

Completed

G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Myelodysplastic Syndrome | Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning

China
Aduro Biotech, Inc.
Johns Hopkins University

Completed

Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer

Metastatic Pancreatic Cancer

United States
Shanghai Jiao Tong University School of Medicine

Completed

PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT

GVHD, Acute

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
Nanfang Hospital of Southern Medical University
Xiangya Hospital of Central South University; Sun Yat-Sen Memorial Hospital... and other collaborators

Completed

Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Stem Cell Transplantation, Hematopoietic

China
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

Hematologic Malignancies

United States
Peking University People's Hospital
The University of Science and Technology of China

Unknown

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate (LAL1913)

Secondary | De Novo | Untreated Philadelphia Positive Acute Lymphoblastic Leukemia | Low-dose Corticosteroids Pretreatment

Italy
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Center for Research Resources (NCRR); Otsuka Pharmaceutical Co., Ltd.

Completed

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

MDS | Lymphomas | Leukemias

United States
Cooperative Study Group A for Hematology

Unknown

Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia (CyATG-FluATG)

Aplastic Anemia

Korea, Republic of
National Cancer Institute (NCI)

Recruiting

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Hematopoietic Stem Cell Transplantation | Immunodeficiency

United States
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Recruiting

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning | Secondary Acute Myeloid Leukemia Evolving From MDS

China
Nanfang Hospital of Southern Medical University
Peking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaborators

Recruiting

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Myelodysplastic Syndrome | Allogeneic Hematopoietic Stem Cell Transplantation | Conditioning

China
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML

Acute Myeloid Leukemia
Sidney Kimmel Cancer Center at Thomas Jefferson...

Terminated

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Lymphoma | Leukemia | Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | AML | Acute Myelogenous Leukemia | Hematologic Malignancy | Myeloma | Non-hodgkin's Lymphoma | CLL | ALL

United States

Search clinical trials for: Cyclophosphamide (CY)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations